Michele Carbone - Publications

Molecular Biosciences and Bioengineering University of Hawai'i at Manoa, Honolulu, HI 
Cell Biology, Molecular Biology, Virology Biology

145 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bononi A, Goto K, Ak G, Yoshikawa Y, Emi M, Pastorino S, Carparelli L, Ferro A, Nasu M, Kim JH, Suarez JS, Xu R, Tanji M, Takinishi Y, Minaai M, ... ... Carbone M, et al. Heterozygous germline mutations increase susceptibility to asbestos and mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. PMID 33318203 DOI: 10.1073/pnas.2019652117  0.48
2020 Xue J, Suarez JS, Minaai M, Li S, Gaudino G, Pass HI, Carbone M, Yang H. HMGB1 as a therapeutic target in disease. Journal of Cellular Physiology. PMID 33107103 DOI: 10.1002/jcp.30125  0.48
2020 Pass HI, Alimi M, Carbone M, Yang H, Goparaju CM. Mesothelioma Biomarkers: Discovery in Search of Validation. Thoracic Surgery Clinics. 30: 395-423. PMID 33012429 DOI: 10.1016/j.thorsurg.2020.08.001  0.48
2020 Xue J, Patergnani S, Giorgi C, Suarez J, Goto K, Bononi A, Tanji M, Novelli F, Pastorino S, Xu R, Caroccia N, Dogan AU, Pass HI, Tognon M, Pinton P, ... ... Carbone M, et al. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy. Proceedings of the National Academy of Sciences of the United States of America. PMID 32999071 DOI: 10.1073/pnas.2007622117  0.48
2020 Pass HI, Alimi M, Carbone M, Yang H, Goparaju CM. Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32699075 DOI: 10.1158/1055-9965.EPI-20-0083  0.48
2020 Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, Krausz T, Pass HI, Yang H, Gaudino G. Biological Mechanisms and Clinical Significance of Mutations in Human Cancer. Cancer Discovery. PMID 32690542 DOI: 10.1158/2159-8290.CD-19-1220  0.48
2020 Carbone M, Arron ST, Beutler B, Bononi A, Cavenee W, Cleaver JE, Croce CM, D'Andrea A, Foulkes WD, Gaudino G, Groden JL, Henske EP, Hickson ID, Hwang PM, Kolodner RD, et al. Tumour predisposition and cancer syndromes as models to study gene-environment interactions. Nature Reviews. Cancer. PMID 32472073 DOI: 10.1038/s41568-020-0265-y  0.48
2020 Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano I, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass HI, Carbone M, Yang H. Expression of Concern: HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 26: 1529. PMID 32169964 DOI: 10.1158/1078-0432.CCR-20-0338  0.48
2019 Carbone M, Adusumilli PS, Alexander HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley-Bosco E, Galateau-Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. Ca: a Cancer Journal For Clinicians. PMID 31283845 DOI: 10.3322/caac.21572  0.48
2019 Tsao MS, Carbone M, Galateau-Salle F, Moreira AL, Nicholson AG, Roden AC, Adjei AA, Aubry MC, Fennell DA, Gomez D, Harpole D, Hesdorffer M, Hirsch FR, Liu G, Malik S, et al. Pathologic considerations and standardization in mesothelioma clinical trials. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31260832 DOI: 10.1016/j.jtho.2019.06.020  0.48
2018 Carbone M, Yang H, Gaudino G. Does Chromothripsis Make Mesothelioma an Immunogenic Cancer? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30598368 DOI: 10.1016/j.jtho.2018.11.006  0.48
2018 Pastorino S, Yoshikawa Y, Pass HI, Emi M, Nasu M, Pagano I, Takinishi Y, Yamamoto R, Minaai M, Hashimoto-Tamaoki T, Ohmuraya M, Goto K, Goparaju C, Sarin KY, Tanji M, ... ... Carbone M, et al. A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018790352. PMID 30376426 DOI: 10.1200/JCO.2018.79.0352  0.48
2018 Daou S, Barbour H, Ahmed O, Masclef L, Baril C, Sen Nkwe N, Tchelougou D, Uriarte M, Bonneil E, Ceccarelli D, Mashtalir N, Tanji M, Masson JY, Thibault P, Sicheri F, ... ... Carbone M, et al. Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1. Nature Communications. 9: 4385. PMID 30349006 DOI: 10.1038/s41467-018-06854-2  0.48
2018 Carbone M, Amelio I, Affar EB, Brugarolas J, Cannon-Albright LA, Cantley LC, Cavenee WK, Chen Z, Croce CM, Andrea A, Gandara D, Giorgi C, Jia W, Lan Q, Mak TW, et al. Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death and Differentiation. PMID 30323273 DOI: 10.1038/s41418-018-0213-5  0.48
2018 Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers M, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, et al. Current and Future Management of Malignant Mesothelioma : A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer and Mesothelioma Applied Research Foundation. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30266660 DOI: 10.1016/j.jtho.2018.08.2036  0.48
2018 Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R. State of the Art: Concise Review Scientific Advances and New Frontiers in Mesothelioma Therapeutics. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29966799 DOI: 10.1016/j.jtho.2018.06.011  0.48
2018 McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, Reungwetwattana T, Mao W, Pass HI, Carbone M, Yang H, Peikert T. State of the Art: Advances in Malignant Pleural Mesothelioma in 2017. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29524617 DOI: 10.1016/j.jtho.2018.02.021  0.48
2017 Szymiczek A, Carbone M, Pastorino S, Napolitano A, Tanji M, Minaai M, Pagano I, Mason JM, Pass HI, Bray MR, Mak TW, Yang H. Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma. Oncogene. PMID 28759042 DOI: 10.1038/onc.2017.266  0.48
2017 Chen Z, Gaudino G, Pass HI, Carbone M, Yang H. Diagnostic and prognostic biomarkers for malignant mesothelioma: an update. Translational Lung Cancer Research. 6: 259-269. PMID 28713671 DOI: 10.21037/tlcr.2017.05.06  0.48
2017 Carbone M, Yang H. Mesothelioma: recent highlights. Annals of Translational Medicine. 5: 238. PMID 28706906 DOI: 10.21037/atm.2017.04.29  0.48
2017 Bononi A, Yang H, Giorgi C, Patergnani S, Pellegrini L, Su M, Xie G, Signorato V, Pastorino S, Morris P, Sakamoto G, Kuchay S, Gaudino G, Pass HI, Napolitano A, ... ... Carbone M, et al. Germline BAP1 mutations induce a Warburg effect. Cell Death and Differentiation. PMID 28665402 DOI: 10.1038/cdd.2017.95  0.48
2017 Bononi A, Giorgi C, Patergnani S, Larson D, Verbruggen K, Tanji M, Pellegrini L, Signorato V, Olivetto F, Pastorino S, Nasu M, Napolitano A, Gaudino G, Morris P, Sakamoto G, ... ... Carbone M, et al. BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature. PMID 28614305 DOI: 10.1038/nature22798  0.48
2017 Szymiczek A, Pastorino S, Larson D, Tanji M, Pellegrini L, Xue J, Li S, Giorgi C, Pinton P, Takinishi Y, Pass HI, Furuya H, Gaudino G, Napolitano A, Carbone M, et al. FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model. Journal of Translational Medicine. 15: 58. PMID 28298211 DOI: 10.1186/s12967-017-1158-z  0.48
2017 Pellegrini L, Xue J, Larson D, Pastorino S, Jube S, Forest KH, Saad-Jube ZS, Napolitano A, Pagano I, Negi VS, Bianchi ME, Morris P, Pass HI, Gaudino G, Carbone M, et al. HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Oncotarget. PMID 28186988 DOI: 10.18632/oncotarget.15152  0.48
2016 Guo Z, Carbone M, Zhang X, Su D, Sun W, Lou J, Gao Z, Shao D, Chen J, Zhang G, Hu J, Chen K, Wang F, Pass HI, Yu H, et al. Improving the accuracy of mesothelioma diagnosis in China. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28007630 DOI: 10.1016/j.jtho.2016.12.006  0.48
2016 Mao W, Zhang X, Guo Z, Gao Z, Pass HI, Yang H, Carbone M. Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China. Jama Oncology. PMID 27918607 DOI: 10.1001/jamaoncol.2016.5487  0.48
2016 Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M, Pastorino S, Szymiczek A, Bononi A, Tanji M, Pagano I, Gaudino G, ... ... Carbone M, et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27834213 DOI: 10.1073/pnas.1612074113  0.48
2016 Larson D, Powers A, Ambrosi JP, Tanji M, Napolitano A, Flores EG, Baumann F, Pellegrini L, Jennings CJ, Buck BJ, McLaurin BT, Merkler D, Robinson C, Morris P, Dogan M, ... ... Carbone M, et al. Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity. Journal of Toxicology and Environmental Health. Part B, Critical Reviews. 19: 213-230. PMID 27705545 DOI: 10.1080/10937404.2016.1195321  0.48
2016 Carbone M, Kanodia S, Chao A, Miller A, Wali A, Weissman D, Adjei A, Baumann F, Boffetta P, Buck B, de Perrot M, Dogan AU, Gavett S, Gualtieri A, Hassan R, et al. Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: 1246-62. PMID 27453164 DOI: 10.1016/j.jtho.2016.04.028  0.48
2016 Carbone M, Shimizu D, Napolitano A, Tanji M, Pass HI, Yang H, Pastorino S. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma. Oncotarget. PMID 27447750 DOI: 10.18632/oncotarget.10653  0.48
2016 Zhang L, Shimizu D, Killeen JL, Honda SA, Lu D, Stanoyevitch A, Lin F, Wang B, Monuki ES, Carbone M. Serous Carcinoma component championed by Heparin Binding-EGF Like Growth Factor (HB-EGF) Predisposing to Metastasis and Recurrence in Stage I Uterine Malignant Mixed Mullerian Tumor. Human Pathology. PMID 26980026 DOI: 10.1016/j.humpath.2016.02.014  0.48
2016 Pass HI, Goparaju C, Espin-Garcia O, Donington J, Carbone M, Patel D, Chen Z, Feld R, Cho J, Gadgeel S, Wozniak A, Chachoua A, Leighl N, Tsao MS, de Perrot M, et al. Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26903362 DOI: 10.1016/j.jtho.2016.02.006  0.32
2016 Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano IS, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass H, Carbone M, Yang H. HMGB1 and its hyper-acetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26733616 DOI: 10.1158/1078-0432.CCR-15-1130  0.48
2015 Carbone M, Flores EG, Emi M, Johnson TA, Tsunoda T, Behner D, Hoffman H, Hesdorffer M, Nasu M, Napolitano A, Powers A, Minaai M, Baumann F, Bryant-Greenwood P, Lauk O, et al. Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s. Plos Genetics. 11: e1005633. PMID 26683624 DOI: 10.1371/journal.pgen.1005633  0.48
2015 Bononi A, Napolitano A, Pass HI, Yang H, Carbone M. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. Expert Review of Respiratory Medicine. 9: 633-54. PMID 26308799 DOI: 10.1586/17476348.2015.1081066  0.48
2015 Croce A, Allegrina M, Rinaudo C, Gaudino G, Yang H, Carbone M. Numerous Iron-Rich Particles Lie on the Surface of Erionite Fibers from Rome (Oregon, USA) and Karlik (Cappadocia, Turkey). Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 21: 1341-7. PMID 26286705 DOI: 10.1017/S1431927615014762  0.48
2015 Gerami P, Yélamos O, Lee CY, Obregon R, Yazdan P, Sholl LM, Guitart GE, Njauw CN, Tsao H. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. Jama Dermatology. PMID 26154183 DOI: 10.1001/jamadermatol.2015.1701  0.48
2015 Klebe S, Driml J, Nasu M, Pastorino S, Zangiabadi A, Henderson D, Carbone M. BAP1 hereditary cancer predisposition syndrome: a case report and review of literature. Biomarker Research. 3: 14. PMID 26140217 DOI: 10.1186/s40364-015-0040-5  0.48
2015 Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores EG, Kendrick B, Lapid D, Powers A, Kanodia S, Pastorino S, Pass HI, Dixit V, Yang H, Carbone M. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. PMID 26119930 DOI: 10.1038/onc.2015.243  0.48
2015 Yang H, Pellegrini L, Napolitano A, Giorgi C, Jube S, Preti A, Jennings CJ, De Marchis F, Flores EG, Larson D, Pagano I, Tanji M, Powers A, Kanodia S, Gaudino G, ... ... Carbone M, et al. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death & Disease. 6: e1786. PMID 26068794 DOI: 10.1038/cddis.2015.153  0.48
2015 Hoffmann PR, Panigada M, Soprana E, Terry F, Bandar IS, Napolitano A, Rose AH, Hoffmann FW, Ndhlovu LC, Belcaid M, Moise L, De Groot AS, Carbone M, Gaudino G, Matsui T, et al. Preclinical development of HIvax: human survivin Highly Immunogenic vaccines. Human Vaccines & Immunotherapeutics. 0. PMID 26042612 DOI: 10.1080/21645515.2015.1050572  0.48
2015 Carbone M, Gaudino G, Yang H. Recent insights emerging from malignant mesothelioma genome sequencing. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 409-11. PMID 25695218 DOI: 10.1097/JTO.0000000000000466  0.48
2015 Baumann F, Buck BJ, Metcalf RV, McLaurin BT, Merkler DJ, Carbone M. The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 731-7. PMID 25668121 DOI: 10.1097/JTO.0000000000000506  0.48
2015 Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, ... ... Carbone M, et al. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 565-76. PMID 25658628 DOI: 10.1097/JTO.0000000000000471  0.48
2015 Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M, Seepo S, Meyerson M, Pass HI. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Research. 75: 264-9. PMID 25488749 DOI: 10.1158/0008-5472.CAN-14-1008  0.32
2015 Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, Yang H, Carbone M. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 36: 76-81. PMID 25380601 DOI: 10.1093/carcin/bgu227  0.48
2014 Gaudino G, Yang H, Carbone M. HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis. Biomedicines. 2: 327-344. PMID 28548074 DOI: 10.3390/biomedicines2040327  0.48
2014 Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A, Baumann F, Weigel T, Friedberg J, Sugarbaker P, Krausz T, Wang E, Powers A, Gaudino G, Kanodia S, ... ... Carbone M, et al. Evaluation of clonal origin of malignant mesothelioma. Journal of Translational Medicine. 12: 301. PMID 25471750 DOI: 10.1186/s12967-014-0301-3  0.48
2014 Zhang L, Comertpay S, Shimizu D, DeMay RM, Carbone M, Honda SA, Eaves JM. Axillary metaplastic breast carcinoma with ipsilateral pectoral invasive ductal carcinoma: an unusual presentation. Case Reports in Oncological Medicine. 2014: 938509. PMID 25364575 DOI: 10.1155/2014/938509  0.4
2014 Rose AH, Bertino P, Hoffmann FW, Gaudino G, Carbone M, Hoffmann PR. Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors. The American Journal of Pathology. 184: 1041-9. PMID 24492200 DOI: 10.1016/j.ajpath.2013.12.008  0.36
2013 Qi F, Okimoto G, Jube S, Napolitano A, Pass HI, Laczko R, Demay RM, Khan G, Tiirikainen M, Rinaudo C, Croce A, Yang H, Gaudino G, Carbone M. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. The American Journal of Pathology. 183: 1654-66. PMID 24160326 DOI: 10.1016/j.ajpath.2013.07.029  0.48
2013 Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nature Reviews. Cancer. 13: 153-9. PMID 23550303  0.48
2013 Bertino P, Panigada M, Soprana E, Bianchi V, Bertilaccio S, Sanvito F, Rose AH, Yang H, Gaudino G, Hoffmann PR, Siccardi A, Carbone M. Fowlpox-based survivin vaccination for malignant mesothelioma therapy. International Journal of Cancer. Journal International Du Cancer. 133: 612-23. PMID 23335100 DOI: 10.1002/ijc.28048  0.48
2013 Croce A, Musa M, Allegrina M, Rinaudo C, Baris YI, Dogan AU, Powers A, Rivera Z, Bertino P, Yang H, Gaudino G, Carbone M. Micro-Raman spectroscopy identifies crocidolite and erionite fibers in tissue sections Journal of Raman Spectroscopy. 44: 1440-1445. DOI: 10.1002/jrs.4286  0.48
2012 Ostroff RM, Mehan MR, Stewart A, Ayers D, Brody EN, Williams SA, Levin S, Black B, Harbut M, Carbone M, Goparaju C, Pass HI. Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool Plos One. 7. PMID 23056237 DOI: 10.1371/journal.pone.0046091  0.48
2012 Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman GE, Thornquist MD, Liu G, de Perrot M, Tsao MS, et al. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. The New England Journal of Medicine. 367: 1417-27. PMID 23050525 DOI: 10.1056/NEJMoa1115050  0.32
2012 Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Journal of Translational Medicine. 10: 179. PMID 22935333 DOI: 10.1186/1479-5876-10-179  0.48
2012 Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5352-63. PMID 22893632 DOI: 10.1158/1078-0432.CCR-12-0628  0.48
2012 Jube S, Rivera ZS, Bianchi ME, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Research. 72: 3290-301. PMID 22552293 DOI: 10.1158/0008-5472.CAN-11-3481  0.48
2012 Carbone M, Yang H. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 598-604. PMID 22065079 DOI: 10.1158/1078-0432.CCR-11-2259  0.48
2012 Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, Gazdar AF, Pass HI, Yang H. Malignant mesothelioma: facts, myths, and hypotheses. Journal of Cellular Physiology. 227: 44-58. PMID 21412769 DOI: 10.1002/jcp.22724  0.48
2011 Qi F, Carbone M, Yang H, Gaudino G. Simian virus 40 transformation, malignant mesothelioma and brain tumors. Expert Review of Respiratory Medicine. 5: 683-97. PMID 21955238 DOI: 10.1586/ers.11.51  0.48
2011 Nasu M, Carbone M, Gaudino G, Ly BH, Bertino P, Shimizu D, Morris P, Pass HI, Yang H. Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth. Genes & Cancer. 2: 576-84. PMID 21901170 DOI: 10.1177/1947601911412375  0.48
2011 Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, ... ... Carbone M, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics. 43: 1022-5. PMID 21874000 DOI: 10.1038/ng.912  0.48
2011 Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. 108: 13618-23. PMID 21788493 DOI: 10.1073/pnas.1105887108  0.48
2011 Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Butnor KJ, Pass HI, Carbone M, Testa JR, Heintz NH, Mossman BT. ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. International Journal of Cancer. Journal International Du Cancer. 129: 1075-86. PMID 21710492 DOI: 10.1002/ijc.25763  0.48
2011 Altomare DA, Menges CW, Xu J, Pei J, Zhang L, Tadevosyan A, Neumann-Domer E, Liu Z, Carbone M, Chudoba I, Klein-Szanto AJ, Testa JR. Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. Plos One. 6: e18828. PMID 21526190 DOI: 10.1371/journal.pone.0018828  0.4
2011 Goparaju CM, Blasberg JD, Volinia S, Palatini J, Ivanov S, Donington JS, Croce C, Carbone M, Yang H, Pass HI. Onconase mediated NFKβ downregulation in malignant pleural mesothelioma. Oncogene. 30: 2767-77. PMID 21317924 DOI: 10.1038/onc.2010.643  0.48
2011 Hillegass JM, Blumen SR, Cheng K, MacPherson MB, Alexeeva V, Lathrop SA, Beuschel SL, Steinbacher JL, Butnor KJ, Ramos-Niño ME, Shukla A, James TA, Weiss DJ, Taatjes DJ, Pass HI, ... Carbone M, et al. Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. International Journal of Cancer. Journal International Du Cancer. 129: 233-44. PMID 20830711 DOI: 10.1002/ijc.25666  0.48
2010 Zhang L, Qi F, Gaudino G, Strianese O, Yang H, Morris P, Pass HI, Nerurkar VR, Bocchetta M, Carbone M. Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes. Genes & Cancer. 1: 1008-20. PMID 21779427 DOI: 10.1177/1947601910395580  0.48
2010 Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT. Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Molecular Cancer. 9: 314. PMID 21159167 DOI: 10.1186/1476-4598-9-314  0.32
2010 Flores RM, Riedel E, Donington JS, Alago W, Ihekweazu U, Krug L, Rosenzweig K, Adusumilli PS, Carbone M, Pass HI. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1649-54. PMID 20871264 DOI: 10.1097/JTO.0b013e3181f1903e  0.48
2010 Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Beuschel SL, Butnor KJ, Testa JR, Pass HI, Carbone M, Steele C, Mossman BT. Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Annals of the New York Academy of Sciences. 1203: 7-14. PMID 20716277 DOI: 10.1111/j.1749-6632.2010.05554.x  0.48
2010 Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences of the United States of America. 107: 12611-6. PMID 20616036 DOI: 10.1073/pnas.1006542107  0.48
2010 Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, ... ... Carbone M, et al. Cancer and inflammation: promise for biologic therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 335-51. PMID 20386472 DOI: 10.1097/CJI.0b013e3181d32e74  0.48
2010 Pass HI, Goparaju C, Ivanov S, Donington J, Carbone M, Hoshen M, Cohen D, Chajut A, Rosenwald S, Dan H, Benjamin S, Aharonov R. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Research. 70: 1916-24. PMID 20160038 DOI: 10.1158/0008-5472.CAN-09-3993  0.32
2009 Carbone M. Feasibility of immunotherapy for lymphangioleiomyomatosis. The American Journal of Pathology. 175: 2252-4. PMID 19893040 DOI: 10.2353/ajpath.2009.090900  0.48
2009 Pass HI, Carbone M. Current status of screening for malignant pleural mesothelioma. Seminars in Thoracic and Cardiovascular Surgery. 21: 97-104. PMID 19822280 DOI: 10.1053/j.semtcvs.2009.06.007  0.48
2009 Shukla A, Bosenberg MW, MacPherson MB, Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR, Mossman BT. Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis. The American Journal of Pathology. 175: 2197-206. PMID 19815709 DOI: 10.2353/ajpath.2009.090400  0.48
2009 Yang H, Nasu M, Strianese O, Rivera Z, Luecke L, Carbone M. The legacy of "miracle mineral": asbestos and cancer. Hawaii Medical Journal. 68: 18-20. PMID 19365925  0.48
2009 Altomare DA, Menges CW, Pei J, Zhang L, Skele-Stump KL, Carbone M, Kane AB, Testa JR. Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 106: 3420-5. PMID 19223589 DOI: 10.1073/pnas.0808816106  0.4
2009 Ivanov SV, Miller J, Lucito R, Tang C, Ivanova AV, Pei J, Carbone M, Cruz C, Beck A, Webb C, Nonaka D, Testa JR, Pass HI. Genomic events associated with progression of pleural malignant mesothelioma. International Journal of Cancer. Journal International Du Cancer. 124: 589-99. PMID 18973227 DOI: 10.1002/ijc.23949  0.32
2008 Carbone M, Pannuti A, Zhang L, Testa JR, Bocchetta M. A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Research. 68: 9488-96. PMID 19010924 DOI: 10.1158/0008-5472.CAN-08-2332  0.48
2008 Bocchetta M, Carbone M. SV40 Tag/p53 complexes actively promote malignant cell growth of human mesothelial cells. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 30: 455. PMID 18853526 DOI: 10.3233/CLO-2008-0446  0.48
2008 Yang H, Testa JR, Carbone M. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Current Treatment Options in Oncology. 9: 147-57. PMID 18709470 DOI: 10.1007/s11864-008-0067-z  0.48
2008 Pass HI, Brewer GJ, Dick R, Carbone M, Merajver S. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. The Annals of Thoracic Surgery. 86: 383-9; discussion 39. PMID 18640301 DOI: 10.1016/j.athoracsur.2008.03.016  0.48
2008 Rivera Z, Strianese O, Bertino P, Yang H, Pass H, Carbone M. The relationship between simian virus 40 and mesothelioma. Current Opinion in Pulmonary Medicine. 14: 316-21. PMID 18520265 DOI: 10.1097/MCP.0b013e3283018220  0.48
2008 Beck AK, Pass HI, Carbone M, Yang H. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Future Oncology (London, England). 4: 341-9. PMID 18518759 DOI: 10.2217/14796694.4.3.341  0.48
2008 Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. The Journal of Thoracic and Cardiovascular Surgery. 135: 620-6, 626.e1-3. PMID 18329481 DOI: 10.1016/j.jtcvs.2007.10.054  0.48
2008 Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Research. 68: 1022-9. PMID 18281476 DOI: 10.1158/0008-5472.CAN-07-5203  0.48
2008 Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. The Annals of Thoracic Surgery. 85: 265-72; discussion 2. PMID 18154821 DOI: 10.1016/j.athoracsur.2007.07.042  0.32
2007 Carbone M, Strianese O, Theos K, Yang H. Mesothelioma. Hawaii Medical Journal. 66: 48-50. PMID 17393919  0.48
2007 Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, Baris YI. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nature Reviews. Cancer. 7: 147-54. PMID 17251920 DOI: 10.1038/nrc2068  0.32
2007 Eliasz S, Carbone M, Bocchetta M. Simian virus 40 and cancer Oncology Reviews. 1: 131-140. DOI: 10.1007/s12156-007-0015-3  0.48
2006 Carbone M, Pass HI. Evolving aspects of mesothelioma carcinogenesis: SV40 and genetic predisposition. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 1: 169-71. PMID 17409848 DOI: 10.1097/01243894-200602000-00012  0.48
2006 Carbone M, Bedrossian CW. The pathogenesis of mesothelioma. Seminars in Diagnostic Pathology. 23: 56-60. PMID 17044196 DOI: 10.1053/j.semdp.2006.08.002  0.48
2006 Rdzanek M, Fresco R, Pass HI, Carbone M. Spindle cell tumors of the pleura: differential diagnosis. Seminars in Diagnostic Pathology. 23: 44-55. PMID 17044195  0.32
2006 Kroczynska B, Cutrone R, Bocchetta M, Yang H, Elmishad AG, Vacek P, Ramos-Nino M, Mossman BT, Pass HI, Carbone M. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proceedings of the National Academy of Sciences of the United States of America. 103: 14128-33. PMID 16966607 DOI: 10.1073/pnas.0604544103  0.48
2006 Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proceedings of the National Academy of Sciences of the United States of America. 103: 10397-402. PMID 16798876 DOI: 10.1073/pnas.0604008103  0.48
2006 Ramos-Nino ME, Testa JR, Altomare DA, Pass HI, Carbone M, Bocchetta M, Mossman BT. Cellular and molecular parameters of mesothelioma. Journal of Cellular Biochemistry. 98: 723-34. PMID 16795078 DOI: 10.1002/jcb.20828  0.48
2006 Kroczynska B, Carbone M. Cross reactivity between many anti-human antibodies for their hamster homologs provide the tools to study the signal transduction pathway activated by asbestos and SV40 in the malignant mesothelioma model. Molecular Carcinogenesis. 45: 537-42. PMID 16649249 DOI: 10.1002/mc.20200  0.48
2006 Carbone M, Barbanti-Brodano G. Viral carcinogenesis Oncology: An Evidence-Based Approach. 214-232. DOI: 10.1007/0-387-31056-8_17  0.48
2005 Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Research. 65: 10273-9. PMID 16288015 DOI: 10.1158/0008-5472.CAN-05-2028  0.48
2005 Carbone M, Rdzanek MA, Rudzinski JJ, De Marco MA, Bocchetta M, Ramos Niño M, Mossman B, Pass HI. SV40 detection in human tumor specimens. Cancer Research. 65: 10120-1. PMID 16267039 DOI: 10.1158/0008-5472.CAN-05-1911  0.48
2005 Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. The New England Journal of Medicine. 353: 1564-73. PMID 16221779 DOI: 10.1056/NEJMoa051185  0.48
2005 Wali A, Morin PJ, Hough CD, Lonardo F, Seya T, Carbone M, Pass HI. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). Lung Cancer (Amsterdam, Netherlands). 48: 19-29. PMID 15777968 DOI: 10.1016/j.lungcan.2004.10.011  0.48
2005 Suzuki M, Toyooka S, Shivapurkar N, Shigematsu H, Miyajima K, Takahashi T, Stastny V, Zern AL, Fujisawa T, Pass HI, Carbone M, Gazdar AF. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene. 24: 1302-8. PMID 15592515 DOI: 10.1038/sj.onc.1208263  0.32
2005 Powers A, Carbone M. Diagnosis of synovial sarcoma of the pleura and differentiation from malignant mesothelioma Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. 543-554. DOI: 10.1007/0-387-28274-2_36  0.48
2005 Bocchetta M, Carbone M. SV40-mediated oncogenesis Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. 34-59. DOI: 10.1007/0-387-28274-2_3  0.48
2005 Baris IY, Carbone M. Genetics and human mesothelioma Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. 364-366. DOI: 10.1007/0-387-28274-2_22  0.48
2004 Pass HI, Bocchetta M, Carbone M. Evidence of an important role for SV40 in mesothelioma. Thoracic Surgery Clinics. 14: 489-95. PMID 15559055 DOI: 10.1016/j.thorsurg.2004.06.003  0.48
2004 Hurtuk MG, Carbone M. A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma. Anticancer Research. 24: 3097-102. PMID 15510595  0.48
2004 Carbone M, Pass HI. Multistep and multifactorial carcinogenesis: when does a contributing factor become a carcinogen? Seminars in Cancer Biology. 14: 399-405. PMID 15489132 DOI: 10.1016/j.semcancer.2004.06.002  0.48
2004 Bocchetta M, Carbone M. Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation. Oncogene. 23: 6484-91. PMID 15322519 DOI: 10.1038/sj.onc.1207855  0.48
2004 Carbone M, Klein G, Gruber J, Wong M. Modern criteria to establish human cancer etiology. Cancer Research. 64: 5518-24. PMID 15289363 DOI: 10.1158/0008-5472.CAN-04-0255  0.48
2004 Pass HI, Vogelzang N, Hahn S, Carbone M. Malignant pleural mesothelioma. Current Problems in Cancer. 28: 93-174. PMID 15197388 DOI: 10.1016/j.currproblcancer.2004.04.001  0.32
2004 Carbone M, Bocchetta M. SV40 and Notch-I: multi-functionality meets pleiotropy Progress in Molecular and Subcellular Biology. 36: 289-305. PMID 15171617  0.48
2004 Carbone M, Rdzanek MA. Pathogenesis of malignant mesothelioma. Clinical Lung Cancer. 5: S46-50. PMID 15117424  0.48
2004 Pass HI, Liu Z, Wali A, Bueno R, Land S, Lott D, Siddiq F, Lonardo F, Carbone M, Draghici S. Gene expression profiles predict survival and progression of pleural mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 849-59. PMID 14871960 DOI: 10.1158/1078-0432.CCR-0607-3  0.48
2003 Gazdar AF, Carbone M. Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clinical Lung Cancer. 5: 177-81. PMID 14667274 DOI: 10.3816/CLC.2003.n.031  0.48
2003 Carbone M, Rudzinski J, Bocchetta M. High throughput testing of the SV40 Large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancers. Virology. 315: 409-14. PMID 14585344 DOI: 10.1016/S0042-6822(03)00547-6  0.48
2003 Carbone M, Burck C, Rdzanek M, Rudzinski J, Cutrone R, Bocchetta M. Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation. Cancer Research. 63: 6125-9. PMID 14559789  0.48
2003 Carbone M, Bocchetta M, Cristaudo A, Emri S, Gazdar A, Jasani B, Lednicky J, Miele L, Mutti L, Pass HI, Ramael M, Rizzo P, Testa JR, Weggen S, Yeung A. SV40 and human brain tumors. International Journal of Cancer. Journal International Du Cancer. 106: 140-2; author reply . PMID 12794770 DOI: 10.1002/ijc.11189  0.48
2003 Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene. 22: 81-9. PMID 12527910 DOI: 10.1038/sj.onc.1206097  0.48
2002 Carbone M, Rizzo P, Powers A, Bocchetta M, Fresco R, Krausz T. Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications. Anticancer Research. 22: 3443-8. PMID 12552937  0.48
2002 Powers A, Carbone M. The role of environmental carcinogens, viruses and genetic predisposition in the pathogenesis of mesothelioma. Cancer Biology & Therapy. 1: 348-53. PMID 12432244 DOI: 10.4161/cbt.1.4.4  0.48
2002 Toyooka S, Carbone M, Toyooka KO, Bocchetta M, Shivapurkar N, Minna JD, Gazdar AF. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene. 21: 4340-4. PMID 12082623 DOI: 10.1038/sj.onc.1205381  0.48
2002 Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Grobelny JV, Jhanwar SC, Pass HI, Testa JR, Carbone M. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene. 21: 1434-42. PMID 11857086 DOI: 10.1038/sj.onc.1205203  0.48
2002 Carbone M, Pass HI. Re: Debate on the link between SV40 and human cancer continues. Journal of the National Cancer Institute. 94: 229-30. PMID 11830615  0.32
2001 Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI, Carbone M. SV40 and the pathogenesis of mesothelioma. Seminars in Cancer Biology. 11: 63-71. PMID 11243900 DOI: 10.1006/scbi.2000.0347  0.48
2001 Carbone M. Seminars in cancer biology: Introduction Seminars in Cancer Biology. 11: 1-3. DOI: 10.1006/scbi.2000.0340  0.48
2000 Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P, Carbone M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proceedings of the National Academy of Sciences of the United States of America. 97: 10214-9. PMID 10954737 DOI: 10.1073/pnas.170207097  0.48
2000 McConnell EE, Carbone M. A comparison of pleural mesotheliomas induced by asbestos or SV40 virus in Syrian golden hamsters Inhalation Toxicology. 12: 173-181.  0.48
1999 Carbone M. Simian virus 40 and human tumors: It is time to study mechanisms Journal of Cellular Biochemistry. 76: 189-193. PMID 10618636 DOI: 10.1002/(SICI)1097-4644(20000201)76:2<189::AID-JCB3>3.0.CO;2-J  0.48
1999 Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, Vainio H, Pass HI, Di Resta I, Carbone M, Linnainmaa K. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Molecular Carcinogenesis. 26: 93-9. PMID 10506753 DOI: 10.1002/(SICI)1098-2744(199910)26:2<93::AID-MC4>3.0.CO;2-Z  0.48
1999 Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proceedings of the National Academy of Sciences of the United States of America. 96: 11519-24. PMID 10500209 DOI: 10.1073/pnas.96.20.11519  0.48
1999 Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours British Journal of Cancer. 81: 54-61. PMID 10487612 DOI: 10.1038/sj.bjc.6690650  0.48
1999 Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological issues in mesothelioma: role of SV40. Journal of Cellular Physiology. 180: 167-72. PMID 10395286 DOI: 10.1002/(SICI)1097-4652(199908)180:2<167::AID-JCP4>3.0.CO;2-Q  0.32
1998 Carbone M. The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans Monaldi Archives For Chest Disease. 53: 193-197. PMID 9689808  0.48
1997 Velders MP, Nieland JD, Rudolf MP, Loviscek K, Weijzen S, De Visser KE, Fatima Macedo M, Carbone M, Kast WM. Identification of peptides for immunotherapy of cancer. It is still worth the effort Critical Reviews in Immunology. 18: 7-27. PMID 9419444 DOI: 10.1615/CritRevImmunol.v18.i1-2.30  0.48
1997 Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: A review of recent developments Oncogene. 15: 1877-1888. PMID 9365233  0.48
1997 De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M, Giordano A. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nature Medicine. 3: 913-6. PMID 9256285 DOI: 10.1038/nm0897-913  0.48
1997 Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, de Bartolomeis A, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A, Pass HI. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nature Medicine. 3: 908-12. PMID 9256284 DOI: 10.1038/nm0897-908  0.48
1996 Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS, Carbone M. Oncogene alterations in primary, recurrent, and metastatic human bone tumors. Journal of Cellular Biochemistry. 63: 37-50. PMID 8891902 DOI: 10.1002/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0  0.48
1990 Carbone M, Levine AS. Oncogenes, antioncogenes, and the regulation of cell growth Trends in Endocrinology and Metabolism. 1: 248-253. DOI: 10.1016/1043-2760(90)90005-N  0.48
Show low-probability matches.